Results from the phase III Suppression of Ovarian Function Trial (SOFT) give hope to young women at increased risk for recurrence of their hormone receptor-positive breast cancer.
A community outreach aims to increase cancer screenings and lower cancer deaths among Native Americans.
Receive monthly updates, including information about web exclusives, events, resources, articles and highlights from new issues—direct to your email inbox. Be among the first to hear the latest news from Cancer Today! Click here to sign up!
Amgen is a supporter of Cancer Today.